JW Asset Management

JW Asset Management is a registered investment adviser based in New York, founded in 1998. The firm specializes in managing hedge funds and private equity funds, with a primary focus on investments in the healthcare sector, alongside interests in pharmaceuticals, agtech, banking, cannabis, consumer products, retail, and wellness. JW Asset Management employs various investment strategies, including sector-oriented equity and event-driven approaches, while maintaining exposure to equities, derivatives, and both corporate and sovereign fixed income. The firm has demonstrated its capabilities through significant investments, such as leading the acquisition of Arbor Pharmaceuticals and serving as the lead investor in TerrAscend Corp.

Jason Klarreich

Executive Vice President and CFO

Jason Wild

President and Chief Investment Officer

22 past transactions

Tyson 2.0

Series A in 2022
Tyson 2.0 is a cannabis company producing cannabis products known for purity, precision, and wide accessibility. Providing consumers an outstanding selection of products, Tyson 2.0 is an extraordinary balance of premium and affordable, full-spectrum cannabis flower, concentrates, and consumables available at retailers nationwide. The company was formed by the legendary boxer, entrepreneur, and icon, Mike Tyson.

Allumia

Series A in 2022
Allumia is a market leader in the delivery of Energy Efficiency-as-a-Service to the commercial sector, with a software and IoT platform that optimizes and automates the process of financing, developing, metering, and maintaining projects. Allumia provides services directly to commercial and industrial customers nationwide as well as through utility partnerships.

Pistil Data

Seed Round in 2021
Pistil Data is the leading market intelligence company for CPG brands and retailers.

Semasio

Series C in 2021
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI. The company was founded in 2019 and is headquartered in Chicago, Illinois.

Cityrow Go

Series A in 2021
Cityrow Go is a rowing-based fitness app for smartphones or tablets. It offers rowing classes programmed to deliver an effective, efficient, and motivating workout to the at-home user.

Semasio

Series B in 2021
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI. The company was founded in 2019 and is headquartered in Chicago, Illinois.

Gage Cannabis

Venture Round in 2020
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.

Semasio

Series A in 2020
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI. The company was founded in 2019 and is headquartered in Chicago, Illinois.

High 12 Brands

Series A in 2019
A brand is not simply a name. It is not just a logo or a website. A brand is an identifier of the larger community in which it resides. We build brands that bring people together, mark a common bond, and thread through the ties of shared social fabric.

Canndescent

Series C in 2019
Canndescent is a state compliant cultivator of premium cannabis. Canndescent's services include a combination of quality management and deep cultivation expertise and abandons traditional strain names, allowing customers to get cannabis flower produced, packaged, and distributed in accordance with all state and local laws.

Semasio

Seed Round in 2019
Semasio is on a mission to power outperformance in a privacy-first world. With access to the world's most comprehensive targeting platform available, our industry-leading advertising solutions are trusted by Fortune 500 companies and emerging brands to increase reach, boost efficiency, and maximize ROI. The company was founded in 2019 and is headquartered in Chicago, Illinois.

Henry's Originals

Series B in 2019
Henry's Originals is a producer of handcrafted cannabis products from family-run farms in Mendocino County. Since launching in mid-2017, Henry’s Original has been featured in the Los Angeles Times, Mashable, SF Gate, Men’s Journal, LA Weekly, and Metro.

GrowGeneration

Post in 2019
GrowGeneration is a private company, whose plan is to open and operate hydroponic and specialty gardening stores and capitalize on the rapid growth from the legalization of marijuana and home gardening. The company is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems, and accessories for hydroponic gardening.

Vitruvias Therapeutics

Series A in 2018
Vitruvias Therapeutics is a start-up generic pharmaceutical company that will focus on developing niche topical generic products that are sold only by prescription. The name of the company is taken from Leonardo da Vinci’s drawing “The Vitruvian Man” which refers to the idealized proportionality of the human figure. The company was founded in 2013 and is based in Montgomery, Alabama.

TerrAscend

Post in 2017
TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. It provides support to patients through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations, and Terra Health Network Inc., a provider of clinical support and education programs led by health care professionals. TerrAscend offers prescription cannabinoids and medical cannabis solutions for patients suffering from chronic pain and debilitating illnesses and focuses on drug research and development, cannabis devices, delivery systems, and hemp health products.

Vensun Pharmaceuticals

Series C in 2016
Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms. As a rapidly emerging generic pharmaceutical company, Vensun has filed several Abbreviated New Drug Applications (ANDAs) with the FDA through its partnerships and currently has over 30 products in active development. We are actively seeking additional opportunities for partnerships, strategic alliances, and product acquisitions to enhance our existing development portfolio.

Establishment Labs

Debt Financing in 2016
Establishment Labs is a medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to the strictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®’s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction. All manufacturing facilities are fully compliant with both FDA and ISO applicable standards.

Establishment Labs

Venture Round in 2015
Establishment Labs is a medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to the strictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®’s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction. All manufacturing facilities are fully compliant with both FDA and ISO applicable standards.
Aralez Pharmaceuticals operates as a pharmaceutical company. The Company focuses on acquiring, developing, and commercializing products primarily in cardiovascular, pain, and other specialty areas. Aralez Pharmaceuticals serves customers worldwide.

Vensun Pharmaceuticals

Series B in 2013
Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms. As a rapidly emerging generic pharmaceutical company, Vensun has filed several Abbreviated New Drug Applications (ANDAs) with the FDA through its partnerships and currently has over 30 products in active development. We are actively seeking additional opportunities for partnerships, strategic alliances, and product acquisitions to enhance our existing development portfolio.

Vensun Pharmaceuticals

Series A in 2012
Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms. As a rapidly emerging generic pharmaceutical company, Vensun has filed several Abbreviated New Drug Applications (ANDAs) with the FDA through its partnerships and currently has over 30 products in active development. We are actively seeking additional opportunities for partnerships, strategic alliances, and product acquisitions to enhance our existing development portfolio.

Arbor Pharmaceuticals

Series B in 2010
Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.